Association between platelet count and mucosal healing in Japanese patients with ulcerative colitis: a cross-sectional study.
Mucosal healing
Platelet
Ulcerative colitis
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
16 Nov 2020
16 Nov 2020
Historique:
received:
16
08
2020
accepted:
10
11
2020
entrez:
17
11
2020
pubmed:
18
11
2020
medline:
15
5
2021
Statut:
epublish
Résumé
Mucosal healing (MH) has been indicated as the therapeutic goal for ulcerative colitis (UC). Platelet count is known as an inflammation evaluation. However, the association between platelet count and MH among patients with UC is still scarce. We therefore assessed this issue among Japanese patients with UC. The study subjects consisted of 345 Japanese patients with UC. Platelet count was divided into quartiles on the basis of the distribution of all study subjects (low, moderate, high, and very high). Several endoscope specialists were responsible for evaluating MH and partial MH, which was defined as a Mayo endoscopic subscore of 0 and 0-1, respectively. Estimations of crude odds ratios (ORs) and their 95% confidence intervals (CIs) for partial MH and MH in relation to platelet count were performed using logistic regression analysis. Age, sex, CRP, steroid use, and anti-Tumor necrosis factor α (TNFα) preparation were selected a priori as potential confounding factors. The percentage of partial MH and MH were 63.2 and 26.1%, respectively. Moderate and very high was independently inversely associated with partial MH (moderate: OR 0.40 [95%CI 0.19-0.810], very high: OR 0.37 [95%CI 0.17-0.77], p for trend = 0.034). Similarly, moderate, high, and very high were independently inversely associated with MH (moderate: OR 0.37 [95% CI 0.18-0.73], high: OR 0.41 [95% CI 0.19-0.83], and very high: OR 0.45 [95% CI 0.21-0.94], p for trend = 0.033) after adjustment for confounding factors. Among patients with UC, platelet count was independently inversely associated with MH.
Sections du résumé
BACKGROUND
BACKGROUND
Mucosal healing (MH) has been indicated as the therapeutic goal for ulcerative colitis (UC). Platelet count is known as an inflammation evaluation. However, the association between platelet count and MH among patients with UC is still scarce. We therefore assessed this issue among Japanese patients with UC.
METHODS
METHODS
The study subjects consisted of 345 Japanese patients with UC. Platelet count was divided into quartiles on the basis of the distribution of all study subjects (low, moderate, high, and very high). Several endoscope specialists were responsible for evaluating MH and partial MH, which was defined as a Mayo endoscopic subscore of 0 and 0-1, respectively. Estimations of crude odds ratios (ORs) and their 95% confidence intervals (CIs) for partial MH and MH in relation to platelet count were performed using logistic regression analysis. Age, sex, CRP, steroid use, and anti-Tumor necrosis factor α (TNFα) preparation were selected a priori as potential confounding factors.
RESULTS
RESULTS
The percentage of partial MH and MH were 63.2 and 26.1%, respectively. Moderate and very high was independently inversely associated with partial MH (moderate: OR 0.40 [95%CI 0.19-0.810], very high: OR 0.37 [95%CI 0.17-0.77], p for trend = 0.034). Similarly, moderate, high, and very high were independently inversely associated with MH (moderate: OR 0.37 [95% CI 0.18-0.73], high: OR 0.41 [95% CI 0.19-0.83], and very high: OR 0.45 [95% CI 0.21-0.94], p for trend = 0.033) after adjustment for confounding factors.
CONCLUSIONS
CONCLUSIONS
Among patients with UC, platelet count was independently inversely associated with MH.
Identifiants
pubmed: 33198664
doi: 10.1186/s12876-020-01538-y
pii: 10.1186/s12876-020-01538-y
pmc: PMC7670794
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
384Références
Inflamm Bowel Dis. 2013 Feb;19(2):332-41
pubmed: 23328771
Int J Colorectal Dis. 2007 Dec;22(12):1429-35
pubmed: 17549498
Intest Res. 2020 May 08;:
pubmed: 32375208
Gastroenterology. 2016 Jan;150(1):96-102
pubmed: 26376350
Inflamm Bowel Dis. 2020 Sep 18;26(10):1579-1587
pubmed: 32232392
J Crohns Colitis. 2011 Oct;5(5):477-83
pubmed: 21939925
Inflamm Bowel Dis. 2013 Apr;19(5):1034-42
pubmed: 23470502
Am J Gastroenterol. 2001 Mar;96(3):776-81
pubmed: 11280550
Gastroenterology. 2010 Feb;138(2):463-8; quiz e10-1
pubmed: 19818785
Annu Rev Immunol. 1998;16:111-35
pubmed: 9597126
Clin Gastroenterol Hepatol. 2016 Sep;14(9):1245-1255.e8
pubmed: 26829025
JGH Open. 2017 Nov 01;1(3):98-104
pubmed: 30483544
Cell Mol Life Sci. 2001 Jan;58(1):4-43
pubmed: 11229815
J Crohns Colitis. 2020 Aug 26;:
pubmed: 32845311
PLoS One. 2014 Jun 26;9(6):e101119
pubmed: 24968121
Gastroenterology. 2011 Oct;141(4):1194-201
pubmed: 21723220
J Med Biochem. 2018 Apr 01;37(2):155-162
pubmed: 30581352
World J Gastroenterol. 2014 Dec 28;20(48):18367-74
pubmed: 25561804
Gut Liver. 2018 Jul 15;12(4):420-425
pubmed: 29945423
Gastroenterol Hepatol. 2016 Oct;39(8):508-15
pubmed: 27020243
Inflamm Bowel Dis. 2010 Feb;16(2):338-46
pubmed: 19637362
Gastroenterology. 1994 Jul;107(1):3-11
pubmed: 8020674
Gastroenterology. 2007 Aug;133(2):412-22
pubmed: 17681162
N Engl J Med. 1987 Dec 24;317(26):1625-9
pubmed: 3317057
Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):15-29
pubmed: 19949430